These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25814352)

  • 1. Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome.
    Sucato V; Novo G; Evola S; Novo S
    Int J Cardiol; 2015; 186():96-7. PubMed ID: 25814352
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic syndrome as a coronary risk factor. Prevention and treatment].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2003 Jul; 59(7):59-65. PubMed ID: 14560351
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin resistance, metabolic syndrome and endothelial dysfunction.
    Bigazzi R; Bianchi S
    J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome as a cluster of risk factors: is the whole greater than the sum of its parts?: comment on "The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis".
    Ding EL; Smit LA; Hu FB
    Arch Intern Med; 2010 Mar; 170(5):484-5. PubMed ID: 20212187
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased morning blood pressure surge and coronary microvascular dysfunction in patient with early stage hypertension.
    Caliskan M; Caliskan Z; Gullu H; Keles N; Bulur S; Turan Y; Kostek O; Ciftci O; Guven A; Aung SM; Muderrisoglu H
    J Am Soc Hypertens; 2014 Sep; 8(9):652-9. PubMed ID: 25224866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between coronary microcirculatory function and aortic stiffness in diabetes.
    Nemes A
    J Am Coll Cardiol; 2008 Feb; 51(5):597-8; author reply 598. PubMed ID: 18237692
    [No Abstract]   [Full Text] [Related]  

  • 7. Additive effect of diabetes mellitus and hypertension on coronary flow velocity reserve and aortic distensibility in patients with negative coronary angiograms.
    Nemes A; Lengyel C; Ungi I; Soliman OI; Csanády M; Forster T
    Diabetes Res Clin Pract; 2008 Nov; 82(2):e9-10. PubMed ID: 18814926
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of metabolic syndrome, recently diagnosed diabetes and hypertension on right ventricular remodeling. Is there difference between risk factors?
    Tadic M; Ivanovic B; Celic V; Kocabay G
    Clin Exp Hypertens; 2014; 36(5):295-301. PubMed ID: 23865506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin resistance syndrome and coronary artery disease.
    Kendall DM; Sobel BE; Coulston AM; Peters Harmel AL; McLean BK; Peragallo-Dittko V; Buse JB; Fonseca VA; Hill JO; Nesto RW; Sunyer FX;
    Coron Artery Dis; 2003 Jun; 14(4):335-48. PubMed ID: 12826934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological approaches to coronary microvascular dysfunction.
    Guarini G; Huqi A; Morrone D; Capozza P; Todiere G; Marzilli M
    Pharmacol Ther; 2014 Dec; 144(3):283-302. PubMed ID: 25004087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of potassium channels in coronary vasodilation.
    Dick GM; Tune JD
    Exp Biol Med (Maywood); 2010 Jan; 235(1):10-22. PubMed ID: 20404014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.
    Carr MC; Brunzell JD
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2601-7. PubMed ID: 15181030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease--do we need to screen our patients?
    Roberts AW; Clark AL; Witte KK
    Diab Vasc Dis Res; 2009 Jul; 6(3):153-63. PubMed ID: 20368207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exercise and diet on chronic disease.
    Roberts CK; Barnard RJ
    J Appl Physiol (1985); 2005 Jan; 98(1):3-30. PubMed ID: 15591300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of
    Mayala HA; Bakari KH; Mkangala A; Magesa M; Mghanga FP; ZhaoHui W
    BMC Res Notes; 2018 Nov; 11(1):796. PubMed ID: 30400961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.
    Zornitzki T; Ayzenberg O; Gandelman G; Vered S; Yaskil E; Faraggi D; Caspi A; Goland S; Shvez O; Schattner A; Knobler H
    QJM; 2007 Sep; 100(9):575-81. PubMed ID: 17693419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases.
    Osborne MT; Bajaj NS; Taqueti VR; Gupta A; Bravo PE; Hainer J; Bibbo CF; Dorbala S; Blankstein R; Di Carli MF
    J Am Coll Cardiol; 2017 Dec; 70(22):2835-2837. PubMed ID: 29191335
    [No Abstract]   [Full Text] [Related]  

  • 18. [New theory turns the cause and effect principle on its head. Diabetes and hypertension--chicken and egg?].
    Zidek W
    MMW Fortschr Med; 2004 Nov; 146(47):44-5. PubMed ID: 15624657
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of physical inactivity with components of metabolic syndrome and coronary artery disease--the Chennai Urban Population Study (CUPS no. 15).
    Mohan V; Gokulakrishnan K; Deepa R; Shanthirani CS; Datta M
    Diabet Med; 2005 Sep; 22(9):1206-11. PubMed ID: 16108850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coronary flow vasodilator reserve in patients with type 2 diabetes mellitus-associated arterial hypertension].
    Karpov RS; Koshel'skaia OA; Soldatenko MV; Efimova EV; Ocheredko NA; Panafidin AV
    Klin Med (Mosk); 2004; 82(6):17-22. PubMed ID: 15344684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.